Artificial Intelligence: Prostate Cancer Diagnosis Now More Accurate With AI

January 21, 2021 | Artificial Intelligence, News
https://dailyalts.com/wp-content/uploads/2021/01/auth_img01.png

A team from the Korea Institute of Science and Technology (KIST) uses AI on urine samples to detect prostate cancer.

Current methods detect prostate cancer with only 30% accuracy and require invasive surgery for a final determination through biopsies. This is highly inconvenient and often results in complications such as bleeding and pain. Prostate cancer is the most common cancer in men. (Science Codex)

Researchers at the Korea Institute of Science and Technology (KIST) led by Dr. Kwan Hyi Lee from the Biomaterials Research Center and Professor In Gab Jeong from Asan Medical Center have developed a process that identifies prostate cancer with nearly 100% accuracy. It uses AI and a urine sample, generating a report in merely 20 minutes.

Since the urine-based method is non-invasive, it is very convenient, quick, and inexpensive for patients.

How it works

The team combined an ultra-sensitive, electrical-signal-based biosensor with an AI model. The system measures trace amounts of selected four cancer factors in urine for diagnosing prostate cancer.

The researchers trained the AI model by using the correlation between the four cancer factors, measured by the sensor.

Once trained, the algorithm identified patients with prostate cancer by analyzing complex patterns of the detected signals.

The system detected the presence of prostate cancer in 76 urinary samples with almost 100 percent accuracy.

Reduction in surgery, cost, and medical staff fatigue

“For patients who need surgery and/or treatments, cancer will be diagnosed with high accuracy by utilizing urine to minimize unnecessary biopsy and treatments, which can dramatically reduce medical costs and medical staff’s fatigue,” Professor Jeong at Asan Medical Center said.

“This research developed a smart biosensor that can rapidly diagnose prostate cancer with almost 100 percent accuracy only through a urine test, and it can be further utilized in the precise diagnoses of other cancers using a urine test,” Dr. Lee at the KIST said.

Related Story:  An AI Program Identifies Prostate Cancer With Almost 100% Accuracy                                                

Free Industry News

Subscribe to our free newsletter for updates and news about alternatives investments.

  • This field is for validation purposes and should be left unchanged.


Shape

Latest Alternative Investment News

https://dailyalts.com/wp-content/uploads/2022/01/Bink-app-shot.png
FinTech: Lloyds To Acquire Stake In Loyalty App Bink
January 4, 2022     FinTech, News

Lloyds Banking Group (LON: LLOY), Britain’s biggest mortgage provider, will acquire a minority stake in loyalty app Bink, according to a report by Sky News for an undisclosed amount that…

https://dailyalts.com/wp-content/uploads/2022/01/Screenshot-2022-01-04-at-22-29-49-Screenshot-Pawson-2.png
Digital Assets: Coinbase CEO Armstrong Said To Have Splurged $133M On Home In LA
January 4, 2022     Digital Assets, News, Real Estate

An iconic property in Bel Air, Los Angeles, designed by internationally acclaimed English architect John Pawson changed hands last month for $133 million and the buyer was Coinbase (NASDAQ: COIN)…

https://dailyalts.com/wp-content/uploads/2022/01/47752022922_e4569a2f0e_c.jpg
Alternative Investments/ESG: VegTech Invest Launches Plant-Based Innovation & Climate ETF

VegTech Invest advisory has launched the VegTech Plant-based Innovation & Climate ETF (Ticker: EATV), its first financial product. The ETF offers exposure to publicly traded companies actively innovating with plants…

https://dailyalts.com/wp-content/uploads/2022/01/Screenshot-2022-01-04-at-18-48-26-超·世界.png
Venture Capital: Chinese AI Startup Parametrix Raises $100M, Turns Unicorn
January 4, 2022     Artificial Intelligence, News, Venture Capital

Chinese AI company Parametrix.ai has raised $100 million in a Series B round led by Sequoia China and joined by existing investors 5Y Capital and Gaorong Capital. Though the valuation…